#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Liposarcoma recurrent Hypereosinophilic syndrome Colorectal cancer metastatic Haemophilia B without inhibitors Hodgkin's disease Ischaemic stroke Demyelination Neuroendocrine carcinoma metastatic Myotonic dystrophy Autoimmune disorder Sarcoidosis Prophylaxis against transplant rejection Thalassaemia alpha Polycythaemia vera Chronic kidney disease More trials…

    Learn about Rare Diseases

    Erdheim-Chester disease Adrenogenital syndrome – Treatment Crigler-Najjar syndrome – Treatment Haemolytic uraemic syndrome – Basic Information Lymphangiosarcoma – Treatment Methylmalonic acidaemia – Diagnostics Choroid melanoma – Trials in Disease Proteus syndrome Angiosarcoma metastatic – Diagnostics Turner’s syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Azd7798 BNT327 Cinnarizine Corline Heparin Conjugate Imipenem Rifamycin Sodium Dexibuprofen Staphylococcus Aureus L-Ascorbic Acid Pantoprazole Belimumab Opelconazole Axicabtagene Ciloleucel Cangrelor Tetrasodium Kpl-404 Tafamidis Pyrazinamide BRENSOCATIB Mps-106 Hepatitis B Surface Antigen More therapies…

    Learn about Your Condition

    Hepatorenal syndrome Oesophageal achalasia Muscle hypertrophy Wolfram syndrome Partial lipodystrophy Intracranial aneurysm Parkinson's disease Hepatotoxicity Breast angiosarcoma metastatic Juvenile spondyloarthritis Eosinophilic oesophagitis Low cardiac output syndrome Hypertriglyceridaemia Gestational diabetes Neurofibrosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Clintrial s.r.o.

Clintrial s.r.o.

Pocernicka 1427/16, Strasnice, Prague, 100 00, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Abatacept Biosimilar (DRL_AB) and Methotrexate for Patients with Moderate to Severe Rheumatoid Arthritis

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Abatacept
    • Methotrexate
    Bulgaria Czechia Estonia Hungary Latvia Lithuania +2

  • Study on RL-007 for Improving Cognitive Impairment in Schizophrenia Patients

    Not recruiting

    2 1
    Investigated Diseases:
    • Cognitive disorder
    • Schizophrenia
    Investigated Drugs:
    • (2R,3S)-2-Amino-3-Hydroxy-3-Pyridin-4-Yl-1-Pyrrolidin-1-Ylpropan-1-One (2R,3R)-2,3-Dihydroxybutanedioic Acid
    Bulgaria Czechia Poland

  • Study of ACP-204 for Treating Psychosis in Adults with Alzheimer’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Acp-204 Tartrate
    Bulgaria Czechia France Italy Spain

  • Long-Term Study of Ritlecitinib Tosilate for Adults and Adolescents with Alopecia Areata

    Not recruiting

    3 1 1
    Czechia Germany Poland Spain

  • Study on the Long-Term Safety of Tavapadon for Patients with Parkinson’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Parkinson’s disease
    Investigated Drugs:
    • Tavapadon
    Bulgaria Czechia France Germany Hungary Italy +2

  • Testing BI 1569912 for Major Depressive Disorder in Patients Using Antidepressants

    Not recruiting

    2 1
    Investigated Diseases:
    • Major depression
    Belgium Bulgaria Czechia Germany

  • Study Comparing Atogepant and Topiramate for Preventive Treatment in Adults with Migraine

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Migraine
    • Migraine with aura
    • Migraine without aura
    Investigated Drugs:
    • Atogepant
    • Topiramate
    Austria Belgium Czechia France Germany Hungary +3

  • Study on the Effects of LEO 138559 for Adults with Moderate-to-Severe Atopic Dermatitis

    Not recruiting

    2 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Humanised Igg1 Monoclonal Antibody Against Interleukin 22 Receptor Subunit Alpha
    Czechia France Germany Hungary Poland Romania +1

  • Study of XPro1595 for Patients with Early Alzheimer’s Disease and Inflammation Markers

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia of the Alzheimer’s type uncomplicated
    Investigated Drugs:
    • Pegipanermin
    Czechia France Germany Poland Slovakia Spain

  • Study on the Effectiveness and Safety of Methotrexate Compared to Placebo for Adults with Moderate to Severe Atopic Dermatitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Desoximetasone
    • Folic Acid
    • Methotrexate
    Czechia France Italy Poland
Previous Page
1 … 5 6 7 8
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!